Murine Herc6 plays a critical role in protein ISGylation in vivo and has an ISGylation-independent function in seminal vesicles

Journal of Interferon and Cytokine Research

Volumn 35, Issue 5, 2015, Pages 351-358

  Arimoto, Kei Ichiro ^a   Hishiki, Takayuki ^b   Kiyonari, Hiroshi ^c   Abe, Takaya ^c   Cheng, Chuyi ^d   Yan, Ming ^a   Fan, Jun Bao ^a   Futakuchi, Mitsuru ^e   Tsuda, Hiroyuki ^f   Murakami, Yoshiki ^g   Suzuki, Hideyuki ^h   Zhang, Dong Er ^a,i   Shimotohno, Kunitada ^j  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b KYOTO UNIVERSITY   (Japan)

^c RIKEN Center for Biosystems Dynamics Research   (Japan)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^f NAGOYA CITY UNIVERSITY   (Japan)

^g OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h NONE   (Japan)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; INTERFERON; POLYINOSINIC POLYCYTIDYLIC ACID; HERC6 PROTEIN, MOUSE; LIPOPOLYSACCHARIDE; UBIQUITIN; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONJUGATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DISRUPTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; SEMINAL VESICLE; SENDAI VIRUS; WESTERN BLOTTING; ANIMAL; CELL LINE; GENE DELETION; GENE LOCUS; GENE ORDER; GENE TARGETING; GENE VECTOR; GENETICS; HYPERTROPHY; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; VESICULAR STOMATITIS; VESICULAR STOMATITIS INDIANA VIRUS;

MURINAE; MUS; SENDAI VIRUS; VESICULAR STOMATITIS VIRUS;

ANIMALS; CELL LINE; GENE DELETION; GENE ORDER; GENE TARGETING; GENETIC LOCI; GENETIC VECTORS; HYPERTROPHY; INTERFERONS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, KNOCKOUT; SEMINAL VESICLES; UBIQUITIN-ACTIVATING ENZYMES; UBIQUITIN-PROTEIN LIGASES; UBIQUITINS; VESICULAR STOMATITIS; VESICULAR STOMATITIS INDIANA VIRUS;

EID: 84928949624     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2014.0113     Document Type: Article

References (29)

1. Arimoto K, Funami K, Saeki Y, Tanaka K, Okawa K, Takeuchi O, Akira S, Murakami Y, Shimotohno K. 2010. Polyubiquitin conjugation to NEMO by triparite motif protein 23 (TRIM23) is critical in antiviral defense. Proc Natl Acad Sci U S A 107(36):15856-15861.
2. Bedford L, Lowe J, Dick LR, Mayer RJ, Brownell JE. 2011. Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nature reviews. Drug Discov 10(1):29-46.
3. Bromfield JJ, Schjenken JE, Chin PY, Care AS, Jasper MJ, Robertson SA. 2014. Maternal tract factors contribute to paternal seminal fluid impact on metabolic phenotype in offspring. Proc Natl Acad Sci U S A 111(6):2200-2205.
4. Burkart C, Arimoto K, Tang T, Cong X, Xiao N, Liu YC, Kotenko SV, Ellies LG, Zhang DE. 2013. Usp18 deficient mammary epithelial cells create an antitumour environment driven by hypersensitivity to IFN-lambda and elevated secretion of Cxcl10. EMBO Mol Med 5(7):967-982.
5. Dastur A, Beaudenon S, Kelley M, Krug RM, Huibregtse JM. 2006. Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells. J Biol Chem 281(7):4334-4338.
6. Durfee LA, Lyon N, Seo K, Huibregtse JM. 2010. The ISG15 conjugation system broadly targets newly synthesized proteins: implications for the antiviral function of ISG15. Mol Cell 38(5):722-732.
7. Guerra S, Caceres A, Knobeloch KP, Horak I, Esteban M. 2008. Vaccinia virus E3 protein prevents the antiviral action of ISG15. PLoS Pathog 4(7):e1000096.
8. Hochrainer K, Mayer H, Baranyi U, Binder B, Lipp J, Krois-mayr R. 2005. The human HERC family of ubiquitin ligases: novel members, genomic organization, expression profiling, and evolutionary aspects. Genomics 85(2):153-164.
9. Hsiang TY, Zhao C, Krug RM. 2009. Interferon-induced ISG15 conjugation inhibits influenza A virus gene expression and replication in human cells. J Virol 83(12):5971-5977.
10. Hsiao NW, Chen JW, Yang TC, Orloff GM, Wu YY, Lai CH, Lan YC, Lin CW. 2010. ISG15 over-expression inhibits replication of the Japanese encephalitis virus in human me-dulloblastoma cells. Antiviral Res 85(3):504-511.
11. Kim KI, Giannakopoulos NV, Virgin HW, Zhang DE. 2004. Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation. Mol Cell Biol 24(21):9592-9600.
12. Kim KI, Yan M, Malakhova O, Luo JK, Shen MF, Zou W, de la Torre JC, Zhang DE. 2006. Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling. Mol Cell Biol 26(2):472-479.
13. Lai C, Struckhoff JJ, Schneider J, Martinez-Sobrido L, Wolff T, Garcia-Sastre A, Zhang DE, Lenschow DJ. 2009. Mice lacking the ISG15 E1 enzyme UbE1L demonstrate increased susceptibility to both mouse-adapted and non-mouse-adapted influenza B virus infection. J Virol 83(2):1147-1151.
14. Lenschow DJ. 2010. Antiviral properties of ISG15. Viruses 2(10):2154-2168.
15. Lenschow DJ, Giannakopoulos NV, Gunn LJ, Johnston C, O'Guin AK, Schmidt RE, Levine B, Virgin HWt. 2005. Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo. J Virol 79(22):13974-13983.
16. Lenschow DJ, Lai C, Frias-Staheli N, Giannakopoulos NV, Lutz A, Wolff T, Osiak A, Levine B, Schmidt RE, Garcia-Sastre A, Leib DA, Pekosz A, Knobeloch KP, Horak I, Virgin HWt. 2007. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci U S A 104(4):1371-1376.
17. Malakhova OA, Zhang DE. 2008. ISG15 inhibits Nedd4 ubi-quitin E3 activity and enhances the innate antiviral response. J Biol Chem 283(14):8783-8787.
18. Okumura A, Lu G, Pitha-Rowe I, Pitha PM. 2006. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc Natl Acad Sci U S A 103(5):1440-1445.
19. Okumura A, Pitha PM, Harty RN. 2008. ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc Natl Acad Sci U S A 105(10):3974-3979.
20. Osiak A, Utermohlen O, Niendorf S, Horak I, Knobeloch KP. 2005. ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol Cell Biol 25(15):6338-6345.
21. Oudshoorn D, van Boheemen S, Sanchez-Aparicio MT, Rajs-baum R, Garcia-Sastre A, Versteeg GA. 2012. HERC6 is the main E3 ligase for global ISG15 conjugation in mouse cells. PLoS One 7(1):e29870.
22. Park JM, Yang SW, Yu KR, Ka SH, Lee SW, Seol JH, Jeon YJ, Chung CH. 2014. Modification of PCNA by ISG15 plays a crucial role in termination of error-prone translesion DNA synthesis. Mol Cell 54(4):626-638.
23. Philip J, Manikandan R, Lamb GH, Desmond AD. 2007. Ejaculatory-duct calculus causing secondary obstruction and infertility. Fertil Steril 88(3):706 e9-e11.
24. Pincetic A, Kuang Z, Seo EJ, Leis J. 2010. The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process. J Virol 84(9):4725-4736.
25. Pryor JP, Hendry WF. 1991. Ejaculatory duct obstruction in subfertile males: analysis of 87 patients. Fertil Steril 56(4):725-730.
26. Shi HX, Yang K, Liu X, Liu XY, Wei B, Shan YF, Zhu LH, Wang C. 2010. Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification. Mol Cell Biol 30(10):2424-2436.
27. Wong JJ, Pung YF, Sze NS, Chin KC. 2006. HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets. Proc Natl Acad Sci U S A 103(28):10735-10740.
28. Yagi T, Tokunaga T, Furuta Y, Nada S, Yoshida M, Tsukada T, Saga Y, Takeda N, Ikawa Y, Aizawa S. 1993. A novel ES cell line, TT2, with high germline-differentiating potency. Anal Biochem 214(1):70-76.
29. Yuan W, Krug RM. 2001. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J 20(3):362-371.